Triple Edge (GLP3)

Triple Edge (GLP3) is CE SUPPS' RTA research product in a 20 mg format. It brings together three major metabolic pathways: GIP, GLP-1, and glucagon. These signals are studied for their roles in appetite, blood sugar, insulin response, energy use, and body-weight control. What makes Triple Edge stand out is the three-part approach. GIP and GLP-1 are closely tied to how the body responds to food, while glucagon is linked to liver metabolism and energy use. Researchers study all three together to get a broader picture of how the body controls fuel, appetite, and energy balance.